BioCorRx Inc (BICX)
OTHER OTC:BICX
US Market

BioCorRx (BICX) Income Statement

5 Followers

BioCorRx Income Statement

Last quarter (Q1 2024), BioCorRx's total revenue was $3.62K, a decrease of -95.63% from the same quarter last year. In Q1, BioCorRx's net income was $-1.24M. See BioCorRx’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 73.80K$ 89.16K$ 213.84K$ 48.27K$ 122.62K$ 240.26K
Cost of Revenue
$ 24.60K$ 35.99K$ 18.95K$ 5.88K$ 95.95K$ 81.67K
Gross Profit
$ 59.62K$ 53.17K$ 213.84K$ 48.27K$ 26.67K$ 158.59K
Operating Expense
$ 4.01M$ 3.88M$ 4.91M$ 5.42M$ 3.05M$ 4.63M
Operating Income
$ -3.93M$ -3.79M$ -4.70M$ -5.37M$ -3.03M$ -4.47M
Net Non Operating Interest Income Expense
$ -200.46K$ -194.04K$ -1.09M$ -565.68K$ -510.96K$ -1.62M
Other Income Expense
$ -199.13K$ 25.49K$ -1.74M$ -797.41K$ 31.80K$ 44.31K
Pretax Income
$ -4.04M$ -3.77M$ -4.38M$ -5.28M$ -3.51M$ -6.05M
Tax Provision
---$ 0.00$ 0.00$ 0.00
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -4.04M$ -3.77M$ -4.34M$ -5.28M$ -3.47M$ -6.04M
Basic EPS
----$ -0.65$ -1.71
Diluted EPS
---$ -0.81$ -0.65$ -1.71
Basic Average Shares
---$ 6.49M$ 5.38M$ 3.52M
Diluted Average Shares
$ 4.74M$ 2.70M$ 1.45M$ 1.06M$ 5.38M$ 3.52M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 4.03M$ 3.91M$ 4.93M$ 5.42M$ 3.15M$ 4.71M
Net Income From Continuing And Discontinued Operation
$ -4.04M$ -3.77M$ -4.38M$ -5.28M$ -3.47M$ -6.04M
Normalized Income
$ -1.41M$ 4.24M$ 3.71M-$ -3.47M$ -6.04M
Interest Expense
----$ 510.96K$ 1.62M
EBIT
$ -3.57M$ -3.81M$ -3.29M$ -4.71M$ -3.00M$ -4.43M
EBITDA
$ -3.03M$ -2.97M$ -2.65M$ -4.65M$ -2.83M$ -4.33M
Currency in USD

BioCorRx Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis